Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-17-017821
Filing Date
2017-07-05
Accepted
2017-07-05 17:57:15
Documents
1
Period of Report
2017-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 3814
  Complete submission text file 0000899243-17-017821.txt   5950
Mailing Address ROCHE HOLDING, LTD. GRENZACHERSTRASSE 124 BASEL V8 CH-4070
Business Address ROCHE HOLDING, LTD. GRENZACHERSTRASSE 124 BASEL V8 CH-4070 9732354295
ROCHE HOLDING LTD (Reporting) CIK: 0000889131 (see all company filings)

State of Incorp.: V8
Type: 3/A | Act: 34 | File No.: 001-38130 | Film No.: 17949379
SIC: 8880 American Depositary Receipts

Mailing Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
Business Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
ROCHE FINANCE LTD (Reporting) CIK: 0001053942 (see all company filings)

State of Incorp.: V8
Type: 3/A | Act: 34 | File No.: 001-38130 | Film No.: 17949378

Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations